(Q40654877)

22 September 2017

1 reference

title

Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. (English)

1 reference

22 September 2017

0 references

Lipton JM

1

1 reference

22 September 2017

Catania A

series ordinal

2

1 reference

22 September 2017

publication date

1 March 1997

1 reference

22 September 2017

1 reference

22 September 2017

volume

18

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

140-145

1 reference

Alpha-melanocyte-stimulating hormone peptides in host responses. From basic evidence to human research

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

The neuropeptide alpha-melanocyte-stimulating hormone: a key component of neuroimmunomodulation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

Cytokine antagonists in infectious and inflammatory disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

The cloning of a family of genes that encode the melanocortin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

Antiinflammatory effects of the neuropeptide alpha-MSH in acute, chronic, and systemic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

Central administration of the peptide α-MSH inhibits inflammation in the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

Central neurogenic antiinflammatory action of alpha-MSH: modulation of peripheral inflammation induced by cytokines and other mediators of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

Effect of bacterial endotoxin and interleukin-1 on prostaglandin biosynthesis by the hippocampus of mouse brain: role of interleukin-1 receptors and glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

Inhibition of IL-1 beta-induced peripheral inflammation by peripheral and central administration of analogs of the neuropeptide alpha-MSH.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

Antiinflammatory influences of alpha-MSH molecules: central neurogenic and peripheral actions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

Low permeability of the blood-brain barrier to nanomolar concentrations of immunoreactive alpha-melanotropin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

Cytokines in Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

The anticytokine neuropeptide alpha-melanocyte-stimulating hormone in synovial fluid of patients with rheumatic diseases: comparisons with other anticytokine molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

Dexamethasone facilitates release of the neuropeptide α-MSH

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

Endotoxin causes release of alpha-melanocyte-stimulating hormone in normal human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

Proopiomelanocortin-derived peptides and cytokines: relations in patients with acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

Plasma concentration of cytokine antagonists in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2901009-8

7 January 2021

10.1016/S0167-5699(97)01009-8

Identifiers

DOI

1 reference

22 September 2017

1 reference